Source: Manufacturing Chemist

Impopharma: Indian Rubicon Research acquires Canadian process development firm

Rubicon has acquired Impopharma Canada with operations in Ontario, Canada as part of its ongoing effort to establish a global development network

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

Chairman & CEO

Theron E. Odlaug

CEO Approval Rating

90/100

Read more